Evidence map›Paper›PMID 35223518›Full record

ReviewFrontiers in oncology2022

The Biological Relevance of NHERF1 Protein in Gynecological Tumors.

Margherita Sonnessa, Sara Sergio, Concetta Saponaro, Michele Maffia, Daniele Vergara, Francesco Alfredo Zito, Andrea Tinelli

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Margherita SonnessaFunctional Biomorphology Laboratory, Pathology Department, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Sara SergioDepartment of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.
Concetta SaponaroFunctional Biomorphology Laboratory, Pathology Department, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Michele MaffiaDepartment of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.
Daniele VergaraDepartment of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.
Francesco Alfredo ZitoFunctional Biomorphology Laboratory, Pathology Department, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Andrea TinelliDepartment of Obstetrics and Gynecology, "Veris delli Ponti" Hospital, Lecce, Italy.
University of Salento · ITIstituto Tumori Bari · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale Veris Delli Ponti Scorrano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gynecological cancer management remains challenging and a better understanding of molecular mechanisms that lead to carcinogenesis and development of these diseases is needed to improve the therapeutic approaches. The Na

Indexed as

cervical cancergynecological cancersNHERF1ovarian cancerWnt/beta-catenin pathway

Identifiers

PMID35223518
PMCPMC8878902
OpenAlexW4211166667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.